Tasimelteon
Back to searchMolecule Structure
Scientific Name
Tasimelteon
Description of the Drug
Tasimelteon is a melatonin receptor agonist used to treat Non- 24-Hour Sleep-Wake Disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09071
http://www.drugbank.ca/drugs/DB09071
Brand Name(s)
Hetlioz, Hetlioz lq
Company Owner(s)
Vanda Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Melatonin receptor | PROTEIN FAMILY | AGONIST | CHEMBL2094268 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3505912 | |
DrugBank | DB09071 | |
PubChem: Thomson Pharma | 15221060 | 46387835 |
PubChem | 10220503 | |
Nikkaji | J3.640.465E | |
EPA CompTox Dashboard | DTXSID70209826 | |
DrugCentral | 4820 | |
ChemicalBook | CB41518537 | |
Guide to Pharmacology | 7393 | |
rxnorm | HETLIOZ | TASIMELTEON |
ChEBI | 79042 | |
ZINC | ZINC000004392649 |